Novartis AG (NVS)
Novartis AG operates in the Drug Manufacturers - General industry of the Healthcare sector, headquartered in Basel, BS, CH. The stock last traded at $153.81, down 0.54% on the session, giving a market capitalisation of $292.35B. On trailing twelve-month figures it carries a trailing P/E of 23.21, a net margin of 23.1%. Its beta of 0.46 implies it has historically moved less than the broad market.
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Novartis AG is most often compared with the following Healthcare names: